STOCK TITAN

Compass Pathways (NASDAQ: CMPS) backs board, pay and auditors at AGM

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Compass Pathways plc reported the results of its 2026 Annual General Meeting held on May 27, 2026. Shareholders representing 58,880,058 ordinary shares were present in person or by proxy. The company did not exercise discretionary voting power over American Depositary Shares lacking voting instructions, which were counted as broker non-votes.

Shareholders re-elected Justin Gover, Daphne Karydas and Jeffrey Jonas as directors and elected Kathleen Tregoning to the board. They also re-appointed PwC UK as U.K. statutory auditors, ratified PwC US as independent registered public accounting firm for 2026 and authorized the Audit and Risk Committee to determine auditors’ remuneration.

Investors approved the receipt of the U.K. statutory annual accounts for the year ended December 31, 2025 and noted that no dividend is recommended for that year. They also approved, on a non-binding, advisory basis, the directors’ remuneration report and the compensation of named executive officers. Following the meeting, Annalisa Jenkins’ eight-year term on the board concluded.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Shares represented at AGM 58,880,058 shares Ordinary shares entitled to vote represented at 2026 AGM
Broker non-votes 76,043,237 shares Broker non-votes reported for each proposal at 2026 AGM
Votes for Kathleen Tregoning 58,735,204 votes For votes on election of director at 2026 AGM
Votes for PwC UK re-appointment 58,755,739 votes For votes re-appointing U.K. statutory auditors
Votes for executive compensation 58,291,006 votes For votes on advisory approval of named executive officer pay
Broker Non-Vote financial
"have been included in the “Broker Non-Vote” total."
non-binding, advisory basis financial
"Ratification, on a non-binding, advisory basis, of the appointment"
independent registered public accounting firm financial
"as the Company’s independent registered public accounting firm for the fiscal year"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
U.K. statutory annual accounts financial
"To receive the U.K. statutory annual accounts and report for the fiscal year"
directors’ remuneration report financial
"the Company's U.K. statutory directors’ remuneration report for the year ended"
0001816590False00018165902026-05-272026-05-27

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 27, 2026
COMPASS PATHWAYS PLC
(Exact Name of Registrant as Specified in Its Charter)
England and Wales001-39522Not applicable
(State or other Jurisdiction of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
33 Broadwick Street
London W1F 0DQ
United Kingdom
(Address of Principal Executive Offices; Zip Code)
+1 (716) 676-6461
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
American Depositary Shares, each representing one ordinary share, nominal value £0.008 per shareCMPSThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.07Submission of Matters to a Vote of Security Holders.
(a) On May 27, 2026, COMPASS Pathways plc (the “Company”) held its 2026 Annual General Meeting of Shareholders (the “AGM”). Of the ordinary shares entitled to vote, there were 58,880,058 ordinary shares represented in person or by proxy at the AGM. The Company did not exercise any of the discretionary voting power with respect to the American Depositary Shares ("ADSs") which is available to the Company pursuant to the terms of the deposit agreement by and among the Company, Citibank, N.A., as depositary, and holders and beneficial owners of ADSs issued thereunder, dated as of September 22, 2020. As a result, the proxy forms for holders of ADSs who did not provide voting instructions on or before the applicable voting cut-off time have been included in the “Broker Non-Vote” total. A “vote withheld” is not a vote in law and votes withheld had no effect on the proposals. Votes withheld were counted as present and entitled to vote for purposes of determining a quorum.

(b) The matters voted upon at the AGM were described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 15, 2026. The final results of such voting are set forth below.
 
Proposal 1. To re-elect Justin Gover as a Director of the Company.
 
FOR AGAINST WITHHELD BROKER NON-VOTES
58,630,954 146,737 102,367 76,043,237
 
At the AGM, Justin Gover was duly re-elected.


Proposal 2. To re-elect Daphne Karydas as a Director of the Company.
 
FOR AGAINST WITHHELD BROKER NON-VOTES
58,621,717185,85272,489 76,043,237

At the AGM, Daphne Karydas was duly re-elected.


Proposal 3. To elect Kathleen Tregoning as a Director of the Company.
 
FOR AGAINST WITHHELD BROKER NON-VOTES
58,735,20467,12277,732 76,043,237

At the AGM, Kathleen Tregoning was duly elected.


Proposal 4. To re-elect Jeffrey Jonas as a Director of the Company.
 
FOR AGAINST WITHHELD BROKER NON-VOTES
58,628,825163,71987,514 76,043,237

At the AGM, Jeffrey Jonas was duly re-elected.




Proposal 5. To re-appoint PricewaterhouseCoopers LLP, an English limited liability partnership (“PwC UK”), as U.K. statutory auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders.
 
FOR AGAINST WITHHELD BROKER NON-VOTES
58,755,73956,04268,277 76,043,237

At the AGM, the shareholders approved the re-appointment of PwC UK as U.K. statutory auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders.


Proposal 6. Ratification, on a non-binding, advisory basis, of the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership (“PwC US”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

FOR AGAINST WITHHELD BROKER NON-VOTES
58,758,21455,04266,802 76,043,237
 
At the AGM, the shareholders ratified the appointment of PwC US as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.


Proposal 7. To authorize the Audit and Risk Committee to determine the auditors’ remuneration for the year ending December 31, 2026.

FOR AGAINST WITHHELD BROKER NON-VOTES
58,743,67262,73973,647 76,043,237

At the AGM, the shareholders authorized the Audit and Risk Committee to determine the auditors’ remuneration for the year ending December 31, 2026. 


Proposal 8. To receive the U.K. statutory annual accounts and report for the fiscal year ended December 31, 2025 and to note that the directors do not recommend the payment of any dividend for the year ended December 31, 2025.

FOR AGAINST WITHHELD BROKER NON-VOTES
58,705,13370,478104,447 76,043,237

At the AGM, the shareholders approved the receipt of the U.K. statutory annual accounts and reports for the year ended December 31, 2025 and to note that the directors do not recommend the payment of any dividend for the year ended December 31, 2025.
 

Proposal 9. To receive and approve, on a non-binding, advisory basis, the Company's U.K. statutory directors’ remuneration report for the year ended December 31, 2025.

FOR AGAINST WITHHELD BROKER NON-VOTES
58,379,024383,453117,581 76,043,237

At the AGM, the Company’s shareholders approved on an advisory basis, the directors’ remuneration report for the year ended December 31, 2025.
 



 
Proposal 10. To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers for the year ended December 31, 2025.

FOR AGAINST WITHHELD BROKER NON-VOTES
58,291,006455,870133,182 76,043,237
At the AGM, the Company’s shareholders approved, on a non-binding and advisory basis, the compensation of the Company’s named executive officers for the year ended December 31, 2025.

As previously disclosed, Dr. Annalisa Jenkins' term as a Class III director was due to expire at the AGM and therefore with the conclusion of the AGM, Dr. Jenkins’ term of service on the board of directors has ended. The board of directors of the Company wishes to express its gratitude to Dr. Jenkins for her dedication to our mission and her invaluable guidance as the Company grew over her eight years serving on the board of directors from a private, early-stage clinical company to a Nasdaq-listed late-stage clinical company preparing for its first regulatory approval and commercial launch.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
COMPASS PATHWAYS PLC
Date: May 28, 2026By:/s/ Kabir Nath
Kabir Nath
Chief Executive Officer

FAQ

What did Compass Pathways (CMPS) shareholders vote on at the 2026 AGM?

Shareholders voted on board elections, auditor appointments, auditor remuneration, receipt of 2025 U.K. statutory accounts, no 2025 dividend, and advisory approvals of the directors’ remuneration report and named executive officer compensation.

Were Compass Pathways (CMPS) directors re-elected at the 2026 AGM?

Yes. Shareholders re-elected Justin Gover, Daphne Karydas and Jeffrey Jonas as directors and elected Kathleen Tregoning to the board. Each director received substantially more votes “for” than “against” or “withheld” in the published tallies.

Did Compass Pathways (CMPS) declare a dividend for 2025 at the AGM?

No. Shareholders approved receiving the U.K. statutory annual accounts for the year ended December 31, 2025 and noted that the directors do not recommend paying any dividend for that financial year.

Which auditors did Compass Pathways (CMPS) shareholders approve for 2026?

Shareholders re-appointed PwC UK as U.K. statutory auditors until the next annual general meeting and, on a non-binding advisory basis, ratified PwC US as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

How many Compass Pathways (CMPS) shares were represented at the 2026 AGM?

A total of 58,880,058 ordinary shares entitled to vote were represented in person or by proxy. Proxy forms for ADS holders without voting instructions were included in the broker non-vote totals under the deposit agreement terms.

What happened to Annalisa Jenkins’ board role at Compass Pathways (CMPS)?

Annalisa Jenkins’ term as a Class III director expired at the 2026 AGM, so her service on the board ended at the meeting’s conclusion. The board expressed gratitude for her eight years of guidance as the company advanced its clinical and listing milestones.

Filing Exhibits & Attachments

3 documents